These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 9832442)

  • 1. Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARgamma agonist) action.
    Zierath JR; Ryder JW; Doebber T; Woods J; Wu M; Ventre J; Li Z; McCrary C; Berger J; Zhang B; Moller DE
    Endocrinology; 1998 Dec; 139(12):5034-41. PubMed ID: 9832442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanisms of action of thiazolidinediones].
    Girard J
    Diabetes Metab; 2001 Apr; 27(2 Pt 2):271-8. PubMed ID: 11452221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiazolidinedione-induced activation of the transcription factor peroxisome proliferator-activated receptor gamma in cells adjacent to the murine skeletal muscle: implications for fibroblast functions.
    Löhrke B; Shahi SK; Krüger B; Schmidt P; Renne U; Dietl G
    Pflugers Arch; 2000 Jan; 439(3):288-96. PubMed ID: 10650980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
    Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM
    Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
    Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
    Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic and acute effects of thiazolidinediones BM13.1258 and BM15.2054 on rat skeletal muscle glucose metabolism.
    Fürnsinn C; Brunmair B; Meyer M; Neschen S; Furtmüller R; Roden M; Kühnle HF; Nowotny P; Schneider B; Waldhäusl W
    Br J Pharmacol; 1999 Nov; 128(6):1141-8. PubMed ID: 10578125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor (PPAR) activation induces tissue-specific effects on fatty acid uptake and metabolism in vivo--a study using the novel PPARalpha/gamma agonist tesaglitazar.
    Hegarty BD; Furler SM; Oakes ND; Kraegen EW; Cooney GJ
    Endocrinology; 2004 Jul; 145(7):3158-64. PubMed ID: 15059948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-gamma-mediated changes in gene expression.
    Brunmair B; Gras F; Neschen S; Roden M; Wagner L; Waldhäusl W; Fürnsinn C
    Diabetes; 2001 Oct; 50(10):2309-15. PubMed ID: 11574413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Euglycemic and hypolipidemic activity of PAT5A: a unique thiazolidinedione with weak peroxisome proliferator activated receptor gamma activity.
    Vikramadithyan RK; Chakrabarti R; Misra P; Premkumar M; Kumar SK; Rao CS; Ghosh A; Reddy KN; Uma C; Rajagopalan R
    Metabolism; 2000 Nov; 49(11):1417-23. PubMed ID: 11092504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [PPARgamma and insulin resistance].
    Girard J
    Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 2):1S19-22. PubMed ID: 12037503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pioglitazone-induced increase of insulin sensitivity in the muscles of the obese Zucker fa/fa rat cannot be explained by local adipocyte differentiation.
    Hallakou S; Foufelle F; Doaré L; Kergoat M; Ferré P
    Diabetologia; 1998 Aug; 41(8):963-8. PubMed ID: 9726600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma.
    De Vos P; Lefebvre AM; Miller SG; Guerre-Millo M; Wong K; Saladin R; Hamann LG; Staels B; Briggs MR; Auwerx J
    J Clin Invest; 1996 Aug; 98(4):1004-9. PubMed ID: 8770873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of insulin signaling in tissues of Zucker obese rats after acute and long-term treatment with PPARgamma agonists.
    Jiang G; Dallas-Yang Q; Li Z; Szalkowski D; Liu F; Shen X; Wu M; Zhou G; Doebber T; Berger J; Moller DE; Zhang BB
    Diabetes; 2002 Aug; 51(8):2412-9. PubMed ID: 12145152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiazolidinedione treatment prevents free fatty acid-induced insulin resistance in male wistar rats.
    Hevener AL; Reichart D; Janez A; Olefsky J
    Diabetes; 2001 Oct; 50(10):2316-22. PubMed ID: 11574414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new, highly selective murine peroxisome proliferator-activated receptor δ agonist increases responsiveness to thermogenic stimuli and glucose uptake in skeletal muscle in obese mice.
    Ngala RA; Stocker CJ; Roy AG; Hislop D; Wargent E; Bell R; Hassall DG; Harling JD; Billin AN; Willson TM; Arch JR; Cawthorne MA
    Diabetes Obes Metab; 2011 May; 13(5):455-64. PubMed ID: 21272187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of different PPARgamma-agonists on MCP-1 expression and monocyte recruitment in experimental glomerulonephritis.
    Panzer U; Schneider A; Guan Y; Reinking R; Zahner G; Harendza S; Wolf G; Thaiss F; Stahl RA
    Kidney Int; 2002 Aug; 62(2):455-64. PubMed ID: 12110006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiazolidinediones influence plasma steroids of male obese Zucker rats.
    Fürnsinn C; Nowotny P; Brunmair B; Gras F; Roden M; Waldhäusl W; Vierhapper H
    Endocrinology; 2002 Jan; 143(1):327. PubMed ID: 11751625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression.
    Kelly LJ; Vicario PP; Thompson GM; Candelore MR; Doebber TW; Ventre J; Wu MS; Meurer R; Forrest MJ; Conner MW; Cascieri MA; Moller DE
    Endocrinology; 1998 Dec; 139(12):4920-7. PubMed ID: 9832429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic rosiglitazone treatment restores AMPKalpha2 activity in insulin-resistant rat skeletal muscle.
    Lessard SJ; Chen ZP; Watt MJ; Hashem M; Reid JJ; Febbraio MA; Kemp BE; Hawley JA
    Am J Physiol Endocrinol Metab; 2006 Feb; 290(2):E251-7. PubMed ID: 16118254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
    Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
    Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.